Ovarian

Oncology·MeSH: Endometrial Neoplasms

Prevalence

18.1 / 100K

Incidence

4.4 / 100K/yr

182 drugs in development·79 companies·1 clinical trial

Drug Pipeline by Phase

Approved(12)

Drug	Company
avmapki fakzynja co-pack	Verastem, Inc. (VSTM)
Aybintio (SB8)	Organon & Co. (OGN)
BRACAnalysis CDx	MYRIAD GENETICS INC (MYGN)
elahere	ImmunoGen, Inc. (IMGN)
Elonva	Organon & Co. (OGN)
Follistim AQ	Organon & Co. (OGN)
ganirelix	Amphastar Pharmaceuticals, Inc. (AMPH)
Lynparza	Merck & Co., Inc. (MRK)
MyChoice CDx	MYRIAD GENETICS INC (MYGN)
ova1	Aspira Women's Health Inc. (AWHL)
overa	Aspira Women's Health Inc. (AWHL)
zejula	TESARO, Inc. (TSRO)

Phase 3(48)

Drug	Company
Acetaminophen	Merck & Co., Inc. (MRK)
Administration of ceralasertib	ASTRAZENECA PLC (AZN)
Administration of ceralasertib in combination with AZD5305	ASTRAZENECA PLC (AZN)
Administration of ceralasertib monotherapy	ASTRAZENECA PLC (AZN)
Aitua Combination Antibody	Valneva SE (VALN)
avutometinib	Verastem, Inc. (VSTM)
AZD5305	ASTRAZENECA PLC (AZN)
cemiplimab+fianlimab fixed dose combination	REGENERON PHARMACEUTICALS, INC. (REGN)
chemotherapy	Incyte Corp. (INCY)
chemotherapy	Zentalis Pharmaceuticals, Inc. (ZNTL)
Datopotamab Deruxtecan	Merck & Co., Inc. (MRK)
Datopotamab Deruxtecan	ENANTA PHARMACEUTICALS INC (ENTA)
defactinib	Verastem, Inc. (VSTM)
fdc fianlimab+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
H1 receptor antagonist	Merck & Co., Inc. (MRK)
H2 receptor antagonist	Merck & Co., Inc. (MRK)
imnn-001	Imunon, Inc. (IMNN)
incb106385	Incyte Corp. (INCY)
incb123667	Incyte Corp. (INCY)
incmga00012	Incyte Corp. (INCY)
MIRV	ELI LILLY & Co (LLY)
MIRV	Merus N.V. (MRUS)
nemvaleukin	Mural Oncology plc (MURA)
New Formulation of Niraparib and Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)
niraparib	GH Research PLC (GHRS)
niraparib	Imunon, Inc. (IMNN)
niraparib	TESARO, Inc. (TSRO)
Niraparib	Merck & Co., Inc. (MRK)
nirogacestat	SpringWorks Therapeutics, Inc. (SWTX)
non-platinum chemotherapy	GENELUX Corp (GNLX)
Olaparib	Novartis AG (NVS)
pamiparib	BeOne Medicines Ltd. (ONC)
pld	GENMAB A/S (GNMSF)
pld	Genmab A/S (GMAB)
regn15505+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
rina-s	GENMAB A/S (GNMSF)
Rina-S	ENANTA PHARMACEUTICALS INC (ENTA)
Sofetabart Mipitecan	Merus N.V. (MRUS)
Sofetabart Mipitecan	ELI LILLY & Co (LLY)
suvemcitug	Apexigen, Inc. (APGN)
T- Dxd	ASTRAZENECA PLC (AZN)
tak-853	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-853	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
topotecan	Genmab A/S (GMAB)
topotecan	Mural Oncology plc (MURA)
topotecan	GENMAB A/S (GNMSF)
Toripalimab	ASTRAZENECA PLC (AZN)
torvutatug samrotecan	ASTRAZENECA PLC (AZN)

Phase 2(51)

Drug	Company
Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)
Aldesleukin	Filana Therapeutics Inc. (FLNA)
BA3011	BioAtla, Inc. (BCAB)
BA3011	ASTRAZENECA PLC (AZN)
BA3021	ASTRAZENECA PLC (AZN)
BA3021	BioAtla, Inc. (BCAB)
brimonidine tartrate ophthalmic solution eye drops	AbbVie Inc. (ABBV)
cyt-0851	Cyteir Therapeutics, Inc. (CYT)
Darolutamide	ENANTA PHARMACEUTICALS INC (ENTA)
ENB003	ASTRAZENECA PLC (AZN)
ENB003	BioAtla, Inc. (BCAB)
fianlimab	REGENERON PHARMACEUTICALS, INC. (REGN)
kevetrin	Innovation Pharmaceuticals Inc. (IPIX)
lartesertib	GH Research PLC (GHRS)
Leuprolide Acetate	Janux Therapeutics, Inc. (JANX)
Leuprolide Acetate	ENANTA PHARMACEUTICALS INC (ENTA)
Lorigerlimab	MACROGENICS INC (MGNX)
lubricating eye drops	AbbVie Inc. (ABBV)
Luveltamab tazevibulin	SUTRO BIOPHARMA, INC. (STRO)
M-CENK	ImmunityBio, Inc. (IBRX)
Mecbotamab vedotin (BA3011)	BioAtla, Inc. (BCAB)
Mirvetuximab Soravtansine	AbbVie Inc. (ABBV)
morab-202	BRISTOL MYERS SQUIBB CO (BMY)
navicixizumab	OncoMed Pharmaceuticals Inc (OMED)
ngc-gem	Processa Pharmaceuticals, Inc. (PCSA)
OG-7191	Organon & Co. (OGN)
olvimulogene nanivacirepvec	GENELUX Corp (GNLX)
Ozuriftamab vedotin (BA3021)	BioAtla, Inc. (BCAB)
pegfilgrastim	Bolt Biotherapeutics, Inc. (BOLT)
Pegfilgrastim	SUTRO BIOPHARMA, INC. (STRO)
platinum chemotherapy	GENELUX Corp (GNLX)
pld	West Pharmaceutical Services Inc. (WST)
pld	REGENERON PHARMACEUTICALS, INC. (REGN)
Raludotatug Deruxtecan	Merck & Co., Inc. (MRK)
sarilumab	West Pharmaceutical Services Inc. (WST)
sarilumab	REGENERON PHARMACEUTICALS, INC. (REGN)
stenoparib	Allarity Therapeutics, Inc. (ALLR)
stenoparib (formerly E7449)	Allarity Therapeutics, Inc. (ALLR)
STRO-002	SUTRO BIOPHARMA, INC. (STRO)
topotecan	BRISTOL MYERS SQUIBB CO (BMY)
Topotecan	SUTRO BIOPHARMA, INC. (STRO)
Toripalimab	BioAtla, Inc. (BCAB)
torl-1-23	Bolt Biotherapeutics, Inc. (BOLT)
trc102	Tracon Pharmaceuticals, Inc. (TCON)
tuvusertib	GH Research PLC (GHRS)
ubamatamab	REGENERON PHARMACEUTICALS, INC. (REGN)
ubamatamab	West Pharmaceutical Services Inc. (WST)
utidelone capsule 35mg/m2/d bid	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
utidelone capsule 40mg/m2/d bid	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
utidelone capsule 50mg/m2/d bid	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
utidelone capsule 75mg/m2/d qd	BIOSTAR PHARMACEUTICALS, INC. (BSPM)

Phase 1(33)

Drug	Company
Aldesleukin	ENANTA PHARMACEUTICALS INC (ENTA)
Aldesleukin	Merus N.V. (MRUS)
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)
cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
CT-1119	Carisma Therapeutics Inc. (CARM)
CTIM-76	Context Therapeutics Inc. (CNTX)
Cytokine-Induced Memory-like Natural Killer Cells	ImmunityBio, Inc. (IBRX)
DT2216	UNITED THERAPEUTICS Corp (UTHR)
emi-le	Mersana Therapeutics, Inc. (MRSN)
felmetatug vedotin	PFIZER INC (PFE)
fpa150	FIVE PRIME THERAPEUTICS, INC. (FPRX)
imgn151	ImmunoGen, Inc. (IMGN)
Interleukin 2	ImmunityBio, Inc. (IBRX)
itil-306	Instil Bio, Inc. (TIL)
LDE225	Novartis AG (NVS)
lira-cel	Anixa Biosciences Inc (ANIX)
lncb74	NextCure, Inc. (NXTC)
LY4337713	ELI LILLY & Co (LLY)
men2501	STEMLINE THERAPEUTICS INC (STML)
mirvetuximab + sl-172154	Shattuck Labs, Inc. (STTK)
navicixizumab	Mereo BioPharma Group plc (MREO)
NeoVax	UNITED THERAPEUTICS Corp (UTHR)
niraparib	Zentalis Pharmaceuticals, Inc. (ZNTL)
NUV-1176	Nuvation Bio Inc. (NUVB)
NX-1607	Nurix Therapeutics, Inc. (NRIX)
NY-ESO-1 TCR/ dnTGFβRII	Merus N.V. (MRUS)
NY-ESO-1 TCR/ dnTGFβRII	ENANTA PHARMACEUTICALS INC (ENTA)
NY-ESO-1 TCR/ dnTGFβRII	Filana Therapeutics Inc. (FLNA)
prolanta	ONCOLIX, INC. (AEPP)
Rintatolimod	Merck & Co., Inc. (MRK)
Rintatolimod	Merus N.V. (MRUS)
Topotecan	ELI LILLY & Co (LLY)
XmAb541	Xencor Inc (XNCR)

Preclinical(13)

Drug	Company
AMHR2-ED ovarian cancer vaccine	Anixa Biosciences Inc (ANIX)
CB-668	Calithera Biosciences, Inc. (CALA)
cryptophycin-adc	Lantern Pharma Inc. (LTRN)
gtb-5550	GT Biopharma, Inc. (GTBP)
ict-140	EOM Pharmaceutical Holdings, Inc. (IMUC)
io112	IO Biotech, Inc. (IOBT)
ost-tadc	OS Therapies Inc (OSTX)
ost-tadc-a	OS Therapies Inc (OSTX)
Ovarian cancer vaccine (AMHR2-ED)	Anixa Biosciences Inc (ANIX)
SNAP-CAR Platform	Coeptis Therapeutics Holdings Inc. (COEP)
theralink pan-tumor assay 1.0	THERALINK TECHNOLOGIES, INC. (THER)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)
zw220	Zymeworks Inc. (ZYME)

Unknown(6)

Drug	Company
Alova	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
MyRisk	MYRIAD GENETICS INC (MYGN)
niraparib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
niraparib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
ovarian cancer car-t therapy	Anixa Biosciences Inc (ANIX)
SJ02	Organon & Co. (OGN)

N/A(1)

Drug	Company
OvaStem™	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Phase 1/Phase 2(8)

Drug	Company
com701	COMPUGEN LTD (CGEN)
olvi-vec	GENELUX Corp (GNLX)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
rina-s	Genmab A/S (GMAB)
skb264	CHINA PHARMA HOLDINGS, INC. (CPHI)
tcr-t library	Alaunos Therapeutics, Inc. (TCRT)
Temozolomide capsule	UNITED THERAPEUTICS Corp (UTHR)
yt023	HWH International Inc. (HWH)

Phase 2/Phase 3(1)

Drug	Company
eik1003	Eikon Therapeutics Inc. (EIKN)

Phase 4(9)

Drug	Company
Administration of ceralasertib and olaparib	ASTRAZENECA PLC (AZN)
Administration of ceralasertib in combination with olaparib	ASTRAZENECA PLC (AZN)
AL	UNITED THERAPEUTICS Corp (UTHR)
bms-986463	BRISTOL MYERS SQUIBB CO (BMY)
Darolutamide	Myovant Sciences Ltd. (MYOV)
Leuprolide Acetate	Myovant Sciences Ltd. (MYOV)
Niraparib oral capsule	UNITED THERAPEUTICS Corp (UTHR)
palacaparib	ASTRAZENECA PLC (AZN)
saruparib	ASTRAZENECA PLC (AZN)

Compare drugs

avmapki fakzynja co-pack vs Aybintio (SB8)avmapki fakzynja co-pack vs BRACAnalysis CDx avmapki fakzynja co-pack vs elahere

Frequently asked questions

How many drugs are in development for Ovarian?

BioSniper tracks 182 drugs in development for Ovarian across 79 companies.

How many clinical trials target Ovarian?

There are 1 clinical trial targeting Ovarian tracked by BioSniper.

What is the prevalence of Ovarian?

The estimated prevalence of Ovarian is approximately 18.1 per 100,000 population.

Deep-dive into Ovarian

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis